Gary Nabel
Fortune : 31 M $ au 31/08/2026
Fortune : 31 M $ au 31/08/2026
Dr. Gary J.
Nabel is an Independent Director at Candel Therapeutics, Inc., a Director & Chief Innovation Officer at OPKO Health, Inc., an Independent Director at SIGA Technologies, Inc. and a President & Chief Executive Officer at ModeX Therapeutics, Inc. He is on the Board of Directors at Candel Therapeutics, Inc., OPKO Health, Inc. and SIGA Technologies, Inc. Dr. Nabel was previously employed as a Chief Scientific Officer & Senior Vice President by Sanofi, a Director-Vaccine Research Center by National Institutes of Health, and a Chairman by Keystone Symposia.
He received his undergraduate degree from Harvard College, a doctorate degree from Harvard University and a doctorate degree from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPKO HEALTH, INC. 2,84 % | 27/05/2025 | 21 185 169 ( 2,84 % ) | 31 M $ | 31/08/2026 |
| 09/06/2026 | 73 754 ( 0,1 % ) | 231 588 $ | 31/08/2026 | |
| 23/06/2026 | 5 353 ( 0,01 % ) | 69 964 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 15/06/2021 |
| OPKO HEALTH, INC. | Directeur/Membre du Conseil | 09/05/2022 |
| CANDEL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/08/2022 |
Modex Therapeutics, Inc.
Modex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops multi-specific immune therapies for cancer and infectious diseases | Directeur Général | 01/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Directeur Technique/Scientifique/R&D | 01/11/2020 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 01/01/2012 |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Operates nonprofit organization that convenes open, peer-reviewed conferences across a broad range of the life sciences | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
SIGA Technologies, Inc.
SIGA Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines and antibiotics | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Operates nonprofit organization that convenes open, peer-reviewed conferences across a broad range of the life sciences | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modex Therapeutics, Inc.
Modex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops multi-specific immune therapies for cancer and infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national